Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (ELDN)

38 filings reported holding ELDN - Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share as of Q4 2021.
Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (ELDN) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 7.88M shares of 79.6M outstanding shares and own 9.9% of the company stock.
Largest 10 shareholders include BVF INC/IL (1.38M shares), Logos Global Management LP (1.34M shares), Cormorant Asset Management, LP (1.31M shares), Woodline Partners LP (781K shares), VANGUARD GROUP INC (670K shares), FMR LLC (504K shares), Point72 Asset Management, L.P. (431K shares), Ikarian Capital, LLC (345K shares), TWO SIGMA ADVISERS, LP (128K shares), and GEODE CAPITAL MANAGEMENT, LLC (127K shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.